# Hengqin Venture Capital

> Hengqin Venture Capital is a VC fund in Guangdong backing Medical and Health Care. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Guangdong, China
- Total investments: 4
- Last investment: Jan 2025
- Lead investor: 50%
- Last updated: Aug 2026

Hengqin Venture Capital is an investment firm that focused on early-stage science and technology innovation project investment.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 75% |
| Health Care | 2 | 50% |
| Sensor | 1 | 25% |
| Hospital | 1 | 25% |
| Biotechnology | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 50% |
| Series A | 2 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Conjustar | Conjustar, a protein-conjugated medicine developer that has rapidly built a robust R&D pipeline through a combination of introduction and independent research and development. it delivers more effective and safer new cancer therapy options to the majority of cancer patients. | $13.6M | Seed | Jan 16, 2025 |  |
| Kunwei Technology | Kunwei Technology manufactures high-precision force sensors (six-axis force sensors) as well as force control systems. It is involved in the research and development, manufacturing, sales, and technological promotion of intelligent force sensors, as well as the development of force sensor products for the robot and other intelligent equipmentindustries. It provides force measurement systems as well as goods connected to measurement and other industries. |  | Series A | Jan 08, 2025 |  |
| Anjieming Medical | Anjieming Medical is a company that creates early glaucoma diagnosis equipment.The company's contact corneal analysis system CID employs dynamic measuring and analysis techniques. It can properly examine many biomechanical features of the cornea using dynamic changes, correct existing intraocular pressure measuring methods, acquire genuineintraocular pressure, and establish a relatively objective glaucoma index. |  | Seed | Nov 13, 2024 |  |
| Enrikenuo | Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs. | $28.1M | Series A |  |  |

4 of 4 investments shown.

## Co-investors
- [Shenzhen Capital Group](https://shizune.co/investors/profile/shenzhen-capital-group) — VC Fund, 2 deals together
- [Chongqing Share](https://shizune.co/investors/profile/chongqing-share) — VC Fund, 1 deal together
- [Fosun Pharma](https://shizune.co/investors/profile/fosun-pharmaceutical) — VC Fund, 1 deal together
- [Green Pine Capital Partners](https://shizune.co/investors/profile/green-pine-capital-partners) — VC Fund, 1 deal together
- [Nanshan Venture Capital](https://shizune.co/investors/profile/nanshan-venture-capital) — VC Fund, 1 deal together
- [Nanshan War Xintou](https://shizune.co/investors/profile/nanshan-war-xintou) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Hengqin Venture Capital invest in?

Hengqin Venture Capital invests primarily in Medical, Health Care and Sensor startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hengqin Venture Capital last invest?

The most recent investment recorded for Hengqin Venture Capital closed in Jan 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co